HRP20110024T1 - Antibakterijski derivati kvinolina - Google Patents

Antibakterijski derivati kvinolina Download PDF

Info

Publication number
HRP20110024T1
HRP20110024T1 HR20110024T HRP20110024T HRP20110024T1 HR P20110024 T1 HRP20110024 T1 HR P20110024T1 HR 20110024 T HR20110024 T HR 20110024T HR P20110024 T HRP20110024 T HR P20110024T HR P20110024 T1 HRP20110024 T1 HR P20110024T1
Authority
HR
Croatia
Prior art keywords
alkyl
aryl
het
mono
compound according
Prior art date
Application number
HR20110024T
Other languages
English (en)
Croatian (hr)
Inventor
Emile Georges Guillemont J�r�me
Dorange Ismet
Francis Alain Lan�ois David
Manuel Villalgordo-Soto Jos�
Ren� Ferdinand Simonnet Yvan
Madeleine Simone Motte Magali
Jozef Lodewijk Marcel Andries Koenraad
Koul Anil
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38048032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110024(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20110024T1 publication Critical patent/HRP20110024T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20110024T 2006-12-06 2011-01-13 Antibakterijski derivati kvinolina HRP20110024T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125545 2006-12-06
PCT/EP2007/063319 WO2008068272A2 (en) 2006-12-06 2007-12-04 Antibacterial quinoline derivatives

Publications (1)

Publication Number Publication Date
HRP20110024T1 true HRP20110024T1 (hr) 2011-04-30

Family

ID=38048032

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110024T HRP20110024T1 (hr) 2006-12-06 2011-01-13 Antibakterijski derivati kvinolina

Country Status (34)

Country Link
US (1) US20100063026A1 (es)
EP (1) EP2099761B1 (es)
JP (1) JP5466013B2 (es)
KR (1) KR101553600B1 (es)
CN (1) CN101547906B (es)
AP (1) AP2477A (es)
AR (1) AR064148A1 (es)
AT (1) ATE486061T1 (es)
AU (1) AU2007328892B2 (es)
BR (1) BRPI0719915A2 (es)
CA (1) CA2668558C (es)
CL (1) CL2007003518A1 (es)
CY (1) CY1112027T1 (es)
DE (1) DE602007010182D1 (es)
DK (1) DK2099761T3 (es)
EA (1) EA016760B1 (es)
ES (1) ES2354755T3 (es)
HK (1) HK1137437A1 (es)
HR (1) HRP20110024T1 (es)
IL (1) IL199082A (es)
JO (1) JO2683B1 (es)
ME (1) ME01230B (es)
MX (1) MX2009005906A (es)
MY (1) MY145940A (es)
NO (1) NO341984B1 (es)
NZ (1) NZ576862A (es)
PL (1) PL2099761T3 (es)
PT (1) PT2099761E (es)
RS (1) RS51582B (es)
SI (1) SI2099761T1 (es)
TW (1) TWI487526B (es)
UA (1) UA101307C2 (es)
WO (1) WO2008068272A2 (es)
ZA (1) ZA200903949B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
EA038350B1 (ru) 2012-04-27 2021-08-12 Янссен Фармацевтика Нв Антибактериальные хинолиновые производные
ES2576491T3 (es) 2012-04-27 2016-07-07 Janssen Pharmaceutica, N.V. Derivados de quinolina antibacterianos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270123A1 (en) * 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
PL222801B1 (pl) * 2002-07-25 2016-09-30 Janssen Pharmaceutica Nv Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je
PT1711181E (pt) * 2004-01-23 2009-12-29 Janssen Pharmaceutica Nv Derivados quinolina e sua utilização como inibidores micobacterianos
AU2005210036B2 (en) * 2004-01-29 2010-12-23 Janssen Pharmaceutica N.V. Quinoline derivatives for use as mycobacterial inhibitors
EP1753427B1 (en) * 2004-05-28 2008-04-02 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
CA2528849C (en) * 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
BRPI0613999B8 (pt) * 2005-06-28 2021-05-25 Janssen Pharmaceutica Nv uso de um composto derivado de quinolina, o referido composto, sua combinação, composição farmacêutica, uso da referida combinação, e produto
JO2752B1 (en) * 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2855B1 (en) * 2005-08-03 2015-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2952B1 (en) * 2005-08-03 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2837B1 (en) * 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents

Also Published As

Publication number Publication date
WO2008068272A3 (en) 2008-07-24
CA2668558A1 (en) 2008-06-12
JO2683B1 (en) 2013-03-03
EA016760B1 (ru) 2012-07-30
NZ576862A (en) 2012-01-12
AR064148A1 (es) 2009-03-18
PT2099761E (pt) 2011-01-18
PL2099761T3 (pl) 2011-04-29
US20100063026A1 (en) 2010-03-11
RS51582B (en) 2011-08-31
EP2099761A2 (en) 2009-09-16
NO341984B1 (no) 2018-03-05
EP2099761B1 (en) 2010-10-27
AU2007328892B2 (en) 2013-05-16
JP2010511672A (ja) 2010-04-15
NO20092541L (no) 2009-09-02
CA2668558C (en) 2016-06-07
AP2477A (en) 2012-09-27
KR20090102778A (ko) 2009-09-30
CL2007003518A1 (es) 2008-07-11
CN101547906B (zh) 2014-08-06
MY145940A (en) 2012-05-31
WO2008068272A2 (en) 2008-06-12
JP5466013B2 (ja) 2014-04-09
ES2354755T3 (es) 2011-03-17
MX2009005906A (es) 2009-06-16
ME01230B (me) 2013-03-20
IL199082A (en) 2014-04-30
BRPI0719915A2 (pt) 2014-03-04
UA101307C2 (ru) 2013-03-25
SI2099761T1 (sl) 2011-02-28
AP2009004873A0 (en) 2009-06-30
ATE486061T1 (de) 2010-11-15
CN101547906A (zh) 2009-09-30
TW200831095A (en) 2008-08-01
HK1137437A1 (en) 2010-07-30
TWI487526B (zh) 2015-06-11
CY1112027T1 (el) 2015-11-04
ZA200903949B (en) 2010-08-25
DK2099761T3 (da) 2011-02-07
KR101553600B1 (ko) 2015-09-16
EA200970537A1 (ru) 2009-10-30
DE602007010182D1 (de) 2010-12-09
AU2007328892A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
HRP20160585T1 (hr) Antibakterijski derivati kinolina
HRP20100428T1 (hr) Antibakterijski derivati kvinolina
JP2010511668A5 (es)
JP2010511667A5 (es)
US20230039712A1 (en) Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
AU2012301953B2 (en) Antibacterial compounds and methods for use
HRP20110540T1 (hr) Antibakterijski derivati kinolina
HRP20131116T1 (hr) Derivati kinolina kao antibakterijska sredstva
HRP20110428T1 (hr) Derivati piperidin-amino-benzimidazola kao inhibitori respiratorne sincitijalne virusne replikacije
AU3122799A (en) Amino compound
EP2750505A1 (en) Antibacterial compounds and methods for use
MY159560A (en) Quinoline derivatives as antibacterial agents
HRP20110024T1 (hr) Antibakterijski derivati kvinolina
HRP20120910T1 (hr) Derivati kinolina kao antibakterijska sredstva
MXPA05007671A (es) Derivados de triazina como absorbedores de uv.
HRP20170044T1 (hr) Derivati kinolina kao antibakterijska sredstva
JPH03133960A (ja) キノロンカルボン酸誘導体、それらを調製する方法および抗ウイルス剤としてのそれらの使用
AR054587A1 (es) Derivados de quinolina antibacterianos
JP2010511671A5 (es)
HRP20090050T3 (en) Novel pyrrolidine-3,4-dicarboxamide derivatives
HRP20120912T1 (hr) Derivati kinolina kao antibakterijska sredstva
HRP20100384T1 (hr) Antibakterijski derivati kvinolina
IL268967B (en) Azetidine derivative
JP2010511670A5 (es)
JP2010511672A5 (es)